in Industry News, News
Battelle, Nanotherapeutics Team Up to Develop Medical Countermeasures for DoD
Battelle and Nanotherapeutics have forged an alliance to research, develop, test and evaluate medical countermeasures for the Defense Department to protect military personnel from chemical, biological, radiological and nuclear threats. The partnership will focus on developing vaccines and therapeutic products against CBRN weapons that pose health risks to U.S. troops deployed worldwide, Battelle said Wednesday. Nanotherapeutics President and CEO Prasad Raje said the […] More